MXPA04003750A - Canal cationico especifico de esperma, catsper2, y usos del mismo. - Google Patents

Canal cationico especifico de esperma, catsper2, y usos del mismo.

Info

Publication number
MXPA04003750A
MXPA04003750A MXPA04003750A MXPA04003750A MXPA04003750A MX PA04003750 A MXPA04003750 A MX PA04003750A MX PA04003750 A MXPA04003750 A MX PA04003750A MX PA04003750 A MXPA04003750 A MX PA04003750A MX PA04003750 A MXPA04003750 A MX PA04003750A
Authority
MX
Mexico
Prior art keywords
catsper2
methods
sperm
cation channel
protein
Prior art date
Application number
MXPA04003750A
Other languages
English (en)
Spanish (es)
Inventor
Ren Dejian
Original Assignee
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Medical Center filed Critical Childrens Medical Center
Publication of MXPA04003750A publication Critical patent/MXPA04003750A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MXPA04003750A 2001-10-22 2004-04-21 Canal cationico especifico de esperma, catsper2, y usos del mismo. MXPA04003750A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34532401P 2001-10-22 2001-10-22

Publications (1)

Publication Number Publication Date
MXPA04003750A true MXPA04003750A (es) 2004-07-23

Family

ID=23354573

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04003750A MXPA04003750A (es) 2001-10-22 2004-04-21 Canal cationico especifico de esperma, catsper2, y usos del mismo.

Country Status (7)

Country Link
US (1) US7339029B2 (enExample)
EP (1) EP1448589A4 (enExample)
JP (1) JP2005512561A (enExample)
AU (1) AU2002364939A1 (enExample)
CA (1) CA2462670A1 (enExample)
MX (1) MXPA04003750A (enExample)
WO (1) WO2003054141A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8729248B2 (en) 2001-10-22 2014-05-20 Children's Medical Center Corporation Sperm-specific cation channel, CATSPER2, and uses therefor
US20050202539A1 (en) * 2004-03-11 2005-09-15 Hydra Biosciences System for screening eukaryotic membrane proteins
US7947866B2 (en) * 2004-10-29 2011-05-24 Genentech, Inc. Gene disruptions, compositions and methods relating thereto
US8394840B2 (en) 2005-06-15 2013-03-12 Hydra Biosciences, Inc. Modulators of sperm hypermotility and uses thereof
WO2014070786A1 (en) 2012-10-29 2014-05-08 The University Of North Carolina At Chapel Hill Compositions and methods for inhibiting pathogen infection
AU2019343952A1 (en) 2018-09-21 2021-04-22 Mucommune, Llc Synthetic binding agents for limiting permeation through mucus
US20220155313A1 (en) * 2019-03-22 2022-05-19 Westfäellsche Wilhelms-Universität Münster Catsper-activity-test for determining male infertility

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001054477A2 (en) 2000-01-25 2001-08-02 Hyseq, Inc. Novel nucleic acids and polypeptides
EP1171460A4 (en) * 1999-04-09 2002-10-09 Human Genome Sciences Inc 48 HUMAN SECRETED PROTEINS
JP2003505082A (ja) 1999-07-26 2003-02-12 ジェネンテック・インコーポレーテッド 新規なポリヌクレオチドとその使用法
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
AU2001274888A1 (en) * 2000-05-19 2001-12-03 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
AU2002305322B2 (en) * 2001-05-03 2008-05-22 Children's Medical Center, Corporation Sperm-specific cation channel, and uses therefor
EP1567644A4 (en) * 2002-04-16 2006-04-05 Origene Technologies Inc GENES AND BATTERIES OF SPECIFIC GENES OF TISSUE
AU2003235096A1 (en) 2002-04-24 2003-11-10 Takeda Chemical Industries, Ltd. Novel protein and dna thereof
GB0212067D0 (en) * 2002-05-24 2002-07-03 Impharmatica Ltd Proteins
WO2004023973A2 (en) * 2002-09-12 2004-03-25 Incyte Corporation Molecules for diagnostics and therapeutics

Also Published As

Publication number Publication date
EP1448589A2 (en) 2004-08-25
JP2005512561A (ja) 2005-05-12
WO2003054141A3 (en) 2004-03-11
CA2462670A1 (en) 2003-07-03
EP1448589A4 (en) 2005-03-30
AU2002364939A1 (en) 2003-07-09
WO2003054141A2 (en) 2003-07-03
US20050142566A1 (en) 2005-06-30
US7339029B2 (en) 2008-03-04

Similar Documents

Publication Publication Date Title
MXPA03010069A (es) Canal de cation especeifico de espermatozoide, y aplicaciones relacionadas con los usos para el mismo.
CN105210981B (zh) 建立可应用于人类疾病研究的雪貂模型的方法及其应用
Chen et al. Embryonic stem cells generated by nuclear transfer of human somatic nuclei into rabbit oocytes
Honda et al. Stable embryonic stem cell lines in rabbits: potential small animal models for human research
Oura et al. Precise CAG repeat contraction in a Huntington’s Disease mouse model is enabled by gene editing with SpCas9-NG
Singh et al. Reproductive biotechniques in buffaloes (Bubalus bubalis): status, prospects and challenges
Schrock et al. Early in vitro fertilization improves development of bovine ova heat stressed during in vitro maturation
Versieren et al. Developmental competence of parthenogenetic mouse and human embryos after chemical or electrical activation
Kadarmideen et al. Genomic selection of in vitro produced and somatic cell nuclear transfer embryos for rapid genetic improvement in cattle production
MXPA04003750A (es) Canal cationico especifico de esperma, catsper2, y usos del mismo.
AU4985201A (en) Human gene critical to fertility
US20090111764A1 (en) Mitochondrial selection
First et al. Genomic potential in mammals
WO2004015066A3 (en) Sperm-specific cation channel, catsper-4, and uses therefor
WO2004015067A3 (en) Sperm-specific cation channel, catsper-3, and uses therefor
Park et al. Production of plasminogen activators (PAs) in bovine cumulus-oocyte complexes during maturation in vitro: effects of epidermal growth factor on production of PAs in oocytes and cumulus cells
Pedersen et al. Basic and practical aspects of pregnancy establishment in cattle
EP1293561A4 (en) EMBRYONAL STEM CELLS ABOLISHED FROM APES
Escribá et al. Heteroparental blastocyst production from microsurgically corrected tripronucleated human embryos
US20090111185A1 (en) Female genome selection
Behr Blastocyst culture and transfer
WO2007095625A3 (en) VOLTAGE-GATED PROTON CHANNEL, Hv1, AND USES THEREFOR
Chen et al. DNA hypomethylation of individual sequences in aborted cloned bovine fetuses
WO2002062395A3 (en) A method and system for introducing a gene into a human stem cell
Suvá et al. First sex modification case in equine cloning